| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cdd6c9aa2a56078633fd99c1537ae |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate |
2021-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6798ca8d5b621b06aed2d21e18c5e76c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3c2ef92912e29936eb92b9f8631bd2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84b9cb76a097925357fa6ca635e8fa8f |
| publicationDate |
2022-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022074572-A1 |
| titleOfInvention |
Substituted tricyclic compounds |
| abstract |
The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; wherein Q is a group of formula Q1 or Q2; wavy bond represents the points of attachment; wherein R 1 is –NR a R b ; R 2 is hydrogen or a C 1 -C 10 alkyl group; R a and R b independently represent hydrogen or a C 1 -C 10 alkyl group, and use of these compounds as kinase inhibitors and compositions comprising the compounds of the present invention. |
| priorityDate |
2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |